Pharmacists in Marksville, LA Accepting Medicare

7 Pharmacists found. Showing 1 - 7

Mr. Kinman P Goux Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 336 Center St, Marksville, LA 71351 Phone: 318-240-9866    Fax: 318-240-8849

Charlene Buck Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Tunica Dr E, Marksville, LA 71351 Phone: 318-253-6519

Dr. Paula Lynette Michot, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 236 S Main St, Marksville, LA 71351 Phone: 318-240-7149

Errol Ponthier Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 236 S Main St, Marksville, LA 71351 Phone: 318-240-7149    Fax: 318-240-7437

Chibuzor Norbert, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Tunica Drive East, Marksville, LA 71351 Phone: 318-253-6519    Fax: 318-253-6556

Equar Negash, PHARMASIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 236 S Main St, Marksville, LA 71351 Phone: 318-240-7149

Mr. Kenneth Wayne Wilson, RPH Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 134 La Rue Medecine St, Marksville, LA 71351 Phone: 318-253-8747

News Archive

Scientists develop software package to predict chemical properties of molecules

Scientists from MIPT's Research Center for Molecular Mechanisms of Aging and Age-Related Diseases together with Inria research center, Grenoble, France have developed a software package called Knodle to determine an atom's hybridization, bond orders and functional groups' annotation in molecules.

Allergy shots are cost-effective and deliver relief in weeks

Allergy shots, an age-old treatment for allergy sufferers, are getting a shot in the arm from new research. This proven therapy saves money; accelerated schedules deliver relief in weeks, rather than months; and alternative methods are on the horizon, according to allergists at the annual scientific meeting of the American College of Allergy, Asthma and Immunology in Boston, Nov 3-8.

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

"What will the day be like when we finally defeat AIDS, tuberculosis and malaria?" Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post's "The Big Push" blog.

BerGenBio begins BGB324 Phase 1b trial in combination with erlotinib in NSCLC patients

BerGenBio AS, an oncology biopharmaceutical company, today announces that its multi-centre open label Phase 1b trial (BGBC004) of BGB324, a selective inhibitor of Axl, in patients with Stage IIIb and Stage IV non-small cell lung cancer (NSCLC) in erlotinib-sensitive and refractory patients who have an activating EGFR mutation, is now underway at the University of Texas MD Anderson Cancer Center, Houston, Oncology Partners, Houston, and at UT Southwestern Medical Center, Dallas, Texas, USA.

Livongo Health secures $20 million in Series B funding

Livongo Health, a consumer digital health company that is empowering people with chronic diseases to live better, announced today that it has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield & Byers (KPCB), DFJ and previous investor General Catalyst.

Read more Medical News

› Verified 9 days ago